UPDATE: MEDIROM Healthcare Technologies Has Received Orders for Over 25,000 MOTHER Bracelet Units
MEDIROM Healthcare Technologies (NASDAQ: MRM) has received orders for over 25,000 MOTHER Bracelet units through its subsidiary MEDIROM MOTHER Labs Inc. These orders include purchases from Japanese companies, notably NFES Technologies and two other major Tokyo Stock Exchange-listed companies.
MEDIROM operates over 300 wellness salons across Japan under the Re.Ra.Ku® brand. The company expanded into health tech in 2015 with the Lav® training app and entered the device business in 2020 with the MOTHER Bracelet®. In 2023, they launched REMONY, a remote monitoring system that has attracted orders from various industries including nursing care, transportation, construction, and manufacturing.
MEDIROM Healthcare Technologies (NASDAQ: MRM) ha ricevuto ordini per oltre 25.000 unità del Braccialetto MOTHER tramite la sua controllata MEDIROM MOTHER Labs Inc. Questi ordini includono acquisti da aziende giapponesi, in particolare NFES Technologies e altre due importanti aziende quotate alla Borsa di Tokyo.
MEDIROM gestisce oltre 300 saloni di benessere in Giappone sotto il marchio Re.Ra.Ku®. L'azienda è entrata nel settore della tecnologia sanitaria nel 2015 con l'app di allenamento Lav® e ha avviato l'attività di dispositivi nel 2020 con il Braccialetto MOTHER®. Nel 2023, hanno lanciato REMONY, un sistema di monitoraggio remoto che ha attratto ordini da vari settori, tra cui assistenza infermieristica, trasporti, costruzioni e manifatturiero.
MEDIROM Healthcare Technologies (NASDAQ: MRM) ha recibido pedidos de más de 25,000 unidades de la Pulsera MOTHER a través de su subsidiaria MEDIROM MOTHER Labs Inc. Estos pedidos incluyen compras de empresas japonesas, destacando a NFES Technologies y otras dos importantes empresas listadas en la Bolsa de Tokio.
MEDIROM opera más de 300 salones de bienestar en Japón bajo la marca Re.Ra.Ku®. La compañía se expandió al sector de tecnología de la salud en 2015 con la aplicación de entrenamiento Lav® y entró en el negocio de dispositivos en 2020 con la Pulsera MOTHER®. En 2023, lanzaron REMONY, un sistema de monitoreo remoto que ha atraído pedidos de diversas industrias, incluyendo el cuidado de enfermería, el transporte, la construcción y la manufactura.
MEDIROM Healthcare Technologies (NASDAQ: MRM)는 자회사인 MEDIROM MOTHER Labs Inc.를 통해 25,000개 이상의 MOTHER 팔찌 주문을 받았습니다. 이 주문에는 일본 기업인 NFES Technologies와 도쿄 증권거래소에 상장된 다른 두 개의 주요 회사로부터의 구매가 포함됩니다.
MEDIROM은 일본 전역에서 Re.Ra.Ku® 브랜드로 300개 이상의 웰니스 살롱을 운영하고 있습니다. 회사는 2015년에 Lav® 트레이닝 앱으로 헬스케어 기술 분야에 진출하였고, 2020년에는 MOTHER Bracelet®와 함께 디바이스 사업에 진입했습니다. 2023년에는 REMONY라는 원격 모니터링 시스템을 출시하여 간호, 운송, 건설 및 제조 등 다양한 산업에서 주문을 받았습니다.
MEDIROM Healthcare Technologies (NASDAQ: MRM) a reçu des commandes de plus de 25 000 unités du Bracelet MOTHER via sa filiale MEDIROM MOTHER Labs Inc. Ces commandes incluent des achats d'entreprises japonaises, notamment NFES Technologies et deux autres grandes entreprises cotées à la Bourse de Tokyo.
MEDIROM exploite plus de 300 salons de bien-être à travers le Japon sous la marque Re.Ra.Ku®. L'entreprise s'est lancée dans la technologie de la santé en 2015 avec l'application de formation Lav® et a pénétré le marché des dispositifs en 2020 avec le Bracelet MOTHER®. En 2023, ils ont lancé REMONY, un système de surveillance à distance qui a attiré des commandes de divers secteurs, y compris les soins infirmiers, le transport, la construction et la fabrication.
MEDIROM Healthcare Technologies (NASDAQ: MRM) hat Aufträge für über 25.000 Einheiten des MOTHER-Armbands über seine Tochtergesellschaft MEDIROM MOTHER Labs Inc. erhalten. Diese Aufträge umfassen Käufe von japanischen Unternehmen, insbesondere NFES Technologies und zwei weiteren großen Unternehmen, die an der Börse Tokio notiert sind.
MEDIROM betreibt über 300 Wellness-Salons in Japan unter der Marke Re.Ra.Ku®. Das Unternehmen trat 2015 mit der Trainings-App Lav® in die Gesundheitstechnik ein und begann 2020 mit dem MOTHER-Armband® im Gerätegeschäft. Im Jahr 2023 haben sie REMONY eingeführt, ein Fernüberwachungssystem, das Bestellungen aus verschiedenen Branchen, darunter Pflege, Transport, Bau und Fertigung, angezogen hat.
- Secured significant orders for 25,000 MOTHER Bracelet units
- Obtained orders from multiple Tokyo Stock Exchange-listed companies, validating product commercialization
- Expanded customer base across diverse industries through REMONY system
- None.
Insights
The 25,000 MOTHER Bracelet orders represent a significant milestone for MEDIROM's health tech expansion. The smart tracker device has gained notable traction with major Tokyo Stock Exchange-listed companies, indicating strong B2B market validation. This order volume marks their largest to date, suggesting growing commercial acceptance of their health monitoring technology.
The MOTHER Bracelet integrates with MEDIROM's broader healthcare ecosystem, including their wellness salons and REMONY remote monitoring system. This strategic positioning in both hardware and software segments strengthens their data collection capabilities across multiple touchpoints. The diversification into corporate wellness monitoring, particularly in high-demand sectors like nursing care and construction, opens substantial recurring revenue opportunities.
The scale of this order has significant implications for MEDIROM's market position and revenue potential. With a current market cap of just
The company's expansion from traditional wellness services into health tech positions them uniquely in the Japanese healthcare market. Their integrated approach combining physical locations, software solutions and now hardware devices creates multiple revenue streams and data monetization opportunities. This could attract investor interest in their digital transformation strategy.
TOKYO, Dec. 09, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (“MEDIROM”) announces that its subsidiary MEDIROM MOTHER Labs Inc. has received orders for over 25,000 MOTHER Bracelet units, including orders from Japanese companies such as NFES Technologies Inc.
“Our long-term mission is for the Mother Bracelet to be revolutionary in the Healthcare Technology and Wellness industries. The 25,000 unit MOTHER Bracelet orders surpasses the amount we’ve received and fulfilled to date and shows the continued momentum of our market penetration. Furthermore, we believe such orders received from not only NFES Technologies but also two other major companies listed on the Tokyo Stock Exchange further validates the commercialization of our technology,” said Kouji Eguchi, CEO, MEDIROM.
About MEDIROM Healthcare Technologies Inc.
MEDIROM, a holistic healthcare company, operates over 300 wellness salons across Japan, Re.Ra.Ku® being its leading brand, and provides healthcare services. In 2015, MEDIROM entered the health tech business and launched new healthcare programs using an on-demand training app called “Lav®”, which is developed by MEDIROM. MEDIROM also entered the device business in 2020 and has developed a smart tracker “MOTHER Bracelet®”. In 2023, MEDIROM launched REMONY, a remote monitoring system for corporate clients, and has received orders from a broad range of industries, including nursing care, transportation, construction, and manufacturing, among others. MEDIROM hopes that its diverse health-related product and service offerings will help it collect and manage healthcare data from users and customers and enable it to become a leader in big data in the healthcare industry. For more information, visit https://medirom.co.jp/en.
Contact:
Investor Relations Team
E-mail:ir@medirom.co.jp
No Offer or Solicitation
This press release and the information contained herein are not, and do not, constitute an offer to sell any securities or a solicitation of an offer to buy any securities in the United States or any other state or jurisdiction, nor shall any securities be offered or sold in any jurisdiction in which such an offer, solicitation or sale would be unlawful.
Forward-Looking Statements Regarding MEDIROM
Certain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about MEDIROM’s possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as “may,” “will,” “should,” “design,” “target,” “aim,” “hope,” “expect,” “could,” “intend,” “plan,” “anticipate,” “estimate,” “believe,” “continue,” “predict,” “project,” “potential,” “goal,” or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to MEDIROM’s future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause MEDIROM’s actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond MEDIROM’s control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects MEDIROM’s current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to MEDIROM’s operations, results of operations, growth strategy and liquidity. Some of the factors that could cause actual results to differ materially from those expressed or implied by the forward-looking statements in this press release include:
- MEDIROM’s ability to achieve its development goals for its business and execute and evolve its growth strategies, priorities and initiatives;
- changes in Japanese and global economic conditions and financial markets, including their effects on MEDIROM’s expansion in Japan and certain overseas markets;
- MEDIROM’s ability to achieve and sustain profitability in its Digital Preventative Healthcare Segment;
- the fluctuation of foreign exchange rates, which affects MEDIROM’s expenses and liabilities payable in foreign currencies;
- MEDIROM’s ability to maintain and enhance the value of its brands and to enforce and maintain its trademarks and protect its other intellectual property;
- MEDIROM’s ability to raise additional capital on acceptable terms or at all;
- MEDIROM’s level of indebtedness and potential restrictions on MEDIROM under MEDIROM’s debt instruments;
- changes in consumer preferences and MEDIROM’s competitive environment;
- MEDIROM’s ability to respond to natural disasters, such as earthquakes and tsunamis, and to global pandemics, such as COVID-19; and
- the regulatory environment in which MEDIROM operates.
More information on these risks and other potential factors that could affect MEDIROM’s business, reputation, results of operations, financial condition, and stock price is included in MEDIROM’s filings with the Securities and Exchange Commission (the “SEC”), including in the “Risk Factors” and “Operating and Financial Review and Prospects” sections of MEDIROM’s most recently filed periodic report on Form 20-F and subsequent filings, which are available on the SEC website at www.sec.gov. MEDIROM assumes no obligation to update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ from those anticipated in these forward-looking statements, even if new information becomes available in the future.
FAQ
How many MOTHER Bracelet units has MEDIROM (MRM) received orders for in December 2023?
What industries are ordering MEDIROM's (MRM) REMONY monitoring system?
How many wellness salons does MEDIROM (MRM) operate in Japan?
